A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.

A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies. Am J Obstet Gynecol. 1984 Dec 15; 150(8):927-31.

View in: PubMed